The STAR II Trial
The STAR II Trial
THE STAR II CLINICAL TRIAL
U.S. FDA APPROVED PIVOTAL IDE TRIAL
TREATMENT OF PATIENTS WITH HAND DYSFUNCTION DUE TO DIFFUSE CUTANEOUS SCLERODERMA
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase III Trial
FDA IDE #: 28142.0; NTC 05148598
THE STAR II CLINICAL TRIAL
U.S. FDA APPROVED PIVOTAL IDE TRIAL
TREATMENT OF PATIENTS WITH HAND DYSFUNCTION
DUE TO DIFFUSE CUTANEOUS SCLERODERMA
A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND,
PLACEBO-CONTROLLED, MULTI-CENTER PHASE III TRIAL
FDA IDE #: 28142.0; NTC 05148598
THE STAR II CLINICAL TRIAL
U.S. FDA APPROVED PIVOTAL IDE TRIAL
TREATMENT OF PATIENTS WITH HAND DYSFUNCTION DUE TO DIFFUSE CUTANEOUS SCLERODERMA
A PROSPECTIVE, RANDOMIZED,
DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE III TRIAL
FDA IDE #: 28142.0; NTC 05148598
TRIAL DESIGN
TRIAL FLOWCHART
TRIAL DESIGN
TRIAL DESIGN
TRIAL FLOWCHART
TRIAL FLOWCHART